Rezuena, Baby Boy .

HRN: 21-72-70  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
AMPICILLIN 500MG (VIAL)
08/15/2022
08/22/2022
IV
170mg
Q12hours
T/c Neonatal Pneumonia; PSNB Sec To Thickly MSAF
Waiting Final Action 
08/15/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
08/15/2022
08/22/2022
IV
17mg
Q24hours
T/c Neonatal Pneumonia; PSNB Sec To Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: